Home
Science
Team
Newsroom
Careers
Contact

News

September 9, 2026

Exclusive: Cancer biotech TwoStep gets $62.5M to take twist on ADCs into clinic

Link to Endpoints Article

Back to articles

Share:

Related Articles

View all articles

News

September 9, 2026

TwoStep Therapeutics Announces Oversubscribed $62.5 Million Series A Financing and FDA Clearance of IND for First-in-Class Peptide-Drug Conjugate

Read article

Presentations

July 20, 2026

TwoStep Therapeutics to Present at the Targeted Radiopharmaceuticals Summit 2026

Read article

Presentations

May 28, 2026

TwoStep Therapeutics to Present at Antibody Engineering & Therapeutics Europe 2026

Read article

Redefining targeted cancer therapy

Home Science Team Newsroom Careers Contact

© 2026 TwoStep Therapeutics. All rights reserved.

MOA animations by Visual Science

© 2026 TwoStep Therapeutics. All rights reserved.

MOA animations by Visual Science